Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02812160 · ClinicalTrials.gov registry record · NA
Spatz Adjustable Balloon for Obesity (SABO)
A NA study of Obesity, sponsored by Spatz FGIA.
- Completed
- Registry status
- NA
- Development phase
- 288
- Enrollment target
- 7
- Study locations
NCT02812160: Completed NA study of Obesity, sponsored by Spatz FGIA.
NCT02812160 is a NA study of Obesity that has completed, run by Spatz FGIA. The registered enrollment target is 288 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (65% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02812160, a NA study of Obesity, has completed, sponsored by Spatz FGIA.
- COMPLETED
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to determine whether the Spatz3 Adjustable balloon, a non-surgical device, is effective in the treatment of obesity.
Primary Outcome
The mean %TBL in the Spatz3 group should exceed the %TBL control group by 4.5%.
Conditions Studied
Interventions
- DEVICE Spatz3 Adjustable Balloon
Study Locations (7)
Illinois
- University of Chicago - Chicago
Louisiana
- Surgical Specialists of Louisiana - Metairie
Maryland
- Endoscopic MicroSurgery Associates - Towson
Massachusetts
- Brigham and Womans Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
New York
- NY Manhattan VA Hospital - New York
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2016-09-12 |
| Est. Completion | 2019-01 |
| Phase | NA |
What the finished NCT02812160 record still lists
NCT02812160 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Spatz3 Adjustable Balloon is the first listed.
NCT02812160 lists 7 locations in 7 states (Illinois, Louisiana, Maryland).
Frequently Asked Questions
What is clinical trial NCT02812160 about?
NCT02812160 is a clinical study titled "Spatz Adjustable Balloon for Obesity (SABO)". The purpose of this study is to determine whether the Spatz3 Adjustable balloon, a non-surgical device, is effective in the treatment of obesity.
What is the current status of trial NCT02812160?
This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2016-09-12. Estimated completion is 2019-01.
What conditions does trial NCT02812160 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT02812160?
The interventions under investigation include: Spatz3 Adjustable Balloon (DEVICE).
Who is sponsoring clinical trial NCT02812160?
This trial is sponsored by Spatz FGIA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02812160 being conducted?
This trial has 7 study locations across Illinois, Louisiana, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02812160's enrollment target sits among peer trials
288 234th of 1053 higher than 819 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI